402 related articles for article (PubMed ID: 26247633)
1. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated silencing of AQP1 expression inhibited the proliferation, invasion and tumorigenesis of osteosarcoma cells.
Wu Z; Li S; Liu J; Shi Y; Wang J; Chen D; Luo L; Qian Y; Huang X; Wang H
Cancer Biol Ther; 2015; 16(9):1332-40. PubMed ID: 26176849
[TBL] [Abstract][Full Text] [Related]
5. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
Chen W; Zhang Y; Fang Z; Qi W; Xu Y
Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
[TBL] [Abstract][Full Text] [Related]
6. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
7. Upregulation and biological function of transmembrane protein 119 in osteosarcoma.
Jiang ZH; Peng J; Yang HL; Fu XL; Wang JZ; Liu L; Jiang JN; Tan YF; Ge ZJ
Exp Mol Med; 2017 May; 49(5):e329. PubMed ID: 28496199
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer.
Dai HY; Ma Y; Da Z; Hou XM
Pathol Res Pract; 2018 Aug; 214(8):1130-1135. PubMed ID: 29929749
[TBL] [Abstract][Full Text] [Related]
9. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma.
Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y
Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779
[TBL] [Abstract][Full Text] [Related]
12. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
Fan W; Du F; Liu X
Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
[TBL] [Abstract][Full Text] [Related]
13. The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells.
Jin PY; Lu HJ; Tang Y; Fan SH; Zhang ZF; Wang Y; Li XN; Wu DM; Lu J; Zheng YL
Biomed Pharmacother; 2017 Dec; 96():1324-1334. PubMed ID: 29203385
[TBL] [Abstract][Full Text] [Related]
14. TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway.
Cao H; Gao R; Chen L; Feng Y
FEBS Open Bio; 2020 Apr; 10(4):515-524. PubMed ID: 31981447
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
16. N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer.
Wang B; Li J; Ye Z; Li Z; Wu X
Oncol Rep; 2014 May; 31(5):2279-85. PubMed ID: 24626771
[TBL] [Abstract][Full Text] [Related]
17. miR-363 acts as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2.
He F; Fang L; Yin Q
Oncol Rep; 2019 May; 41(5):2729-2738. PubMed ID: 30896877
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway.
Wang WG; Chen SJ; He JS; Li JS; Zang XF
Tumour Biol; 2016 Jul; 37(7):8869-77. PubMed ID: 26750098
[TBL] [Abstract][Full Text] [Related]
19. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
20. Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines.
Xiong W; Zhou Q; Liu G; Liu XS; Li XY
Tumour Biol; 2017 May; 39(5):1010428317697566. PubMed ID: 28474998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
